KETALAR Safety Questions, KETALAR Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about KETALAR. Our extensive database of KETALAR adverse events and KETALAR warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about KETALAR
KETALAR Safety Reports
Total KETALAR reports: 6.KETALAR FDA safety alerts: No.
.
Take KETALAR Side Effects Survey or Share Your KETALAR Story. KETALAR Usage.
Pharmacist from UNITED STATES reported KETALAR problem on July 31, 2007. Female patient was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, pain, unwanted awareness during anaesthesia. KETALAR dosage: unknown. Patient recovered.
KETALAR problem was reported by a Physician from GERMANY on July 22, 2007. Female patient was diagnosed with complex regional pain syndrome, sedation and was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: agitation, anxiety, nightmare. KETALAR dosage: 1 MG/KG, BOLUS. During the same period patient was treated with MIDAZOLAM. Patient recovered.
Physician from JAPAN reported KETALAR problem on Aug 24, 2007. Male patient, 63 years of age, weighting 156.5 lb, was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: arteriospasm coronary, autonomic nervous system imbalance, coronary artery stenosis, electromechanical dissociation, shock, ventricular hypokinesia. KETALAR dosage: DAILY DOSE:60MG-FREQ:DAILY. During the same period patient was treated with MUSCULAX, PROPOFOL, DORMICUMECTION, HORIZON, ROXATIDINE ACETATE, NITOROL, SIGMART, HERBESSER. Patient recovered.
KETALAR problem was reported by a Pharmacist from UNITED STATES on Sept 04, 2007. Male patient was diagnosed with nuclear magnetic resonance imaging and was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: agitation, crying, pain. KETALAR dosage: 6 MG/KG TOTAL INCREMENTAL DOSES IV BOLUS. Patient recovered.
Physician from UNITED STATES reported KETALAR problem on Sept 10, 2007. Female patient was diagnosed with induction of anaesthesia, secretion discharge and was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: bradycardia, supraventricular tachycardia. KETALAR dosage: 5 MG, TWO DOSES. During the same period patient was treated with SEVOFLURANE, SUCCINYLCHOLINE CHLORIDE, PROPRANOLOL, MISTABRON, MUCOSOLVAN, RECOMBINANT ACID X. Patient recovered.
KETALAR problem was reported by a Physician from UNITED STATES on Sept 10, 2007. Female patient was diagnosed with induction of anaesthesia and was treated with KETALAR. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, electrocardiogram st-t segment depression, heart rate increased. KETALAR dosage: .5 MG/KG, UNK. During the same period patient was treated with FENTANYL, RECOMBINANT ACID X. Patient recovered.